72 results
8-K
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
the SEPA by mutual written consent.
As consideration for Yorkville’s commitment to purchase the shares of common stock pursuant to the SEPA … , Celularity paid Yorkville a $25,000 cash due diligence fee and a commitment fee equal to 16,964 shares of Common Stock.
The SEPA contains customary
8-K
EX-10.1
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
; Mechanics. Upon the terms and subject to the conditions of this Agreement, during the Commitment Period, (i) the Company, at its sole discretion, shall have … . At any time during the Commitment Period the Company may require the Investor to purchase Shares by delivering an Advance Notice to the Investor
8-K
EX-10.3
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
in such Prospectus.
(f) “Registrable Securities” means all of (i) the Shares (as defined in the Purchase Agreement) and Commitment Shares (as defined … in the Purchase Agreement), (ii) any capital stock issued or issuable with respect to the Shares and Commitment Shares, including, without limitation
8-K
EX-10.3
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
an offering and/or sale of Registrable Securities by the Holder on a block trade or underwritten basis (whether firm commitment or otherwise) without … or a portion of the Registrable Securities (or have signed a firm commitment underwriting agreement with respect to the sale of such Registrable Securities
8-K
EX-10.8
CELU
Celularity Inc - Ordinary Shares
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
an offering and/or sale of Registrable Securities by the Holder on a block trade or underwritten basis (whether firm commitment or otherwise) without … of the Registrable Securities (or have signed a firm commitment underwriting agreement with respect to the sale of such Registrable Securities) pursuant
8-K
EX-10.9
fyjbo5x2fcroouftlyk
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
u7fm5 xs1
7 Sep 23
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
4:21pm
8-K
EX-10.1
80tb3o
25 Aug 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.3
qul60qgp3oj6poar47yb
28 Jul 23
Celularity Inc. Announces $3 Million Registered Direct Offering
4:27pm
8-K
EX-10.3
cyv28
6 Apr 23
Celularity Inc. Announces $6 Million Registered Direct Offering
8:58pm
8-K
EX-99.1
bd8v1d4 1v
10 Nov 22
Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:19pm
8-K
EX-10.1
2sfsuq
15 Sep 22
Entry into a Material Definitive Agreement
4:11pm
424B5
a9wzavebvb4gr2q7bs
15 Sep 22
Prospectus supplement for primary offering
4:06pm